EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women

Maturitas

Volumn 74, Issue 3, 2013, Pages 279-282

  Pérez López, Faustino R ^a   Ceausu, Iuliana ^b,c   Depypere, Herman ^d   Tamer Erel, C ^e   Lambrinoudaki, Irene ^f   Rees, Margaret ^g   Schenck Gustafsson, Karin ^h   Tremollieres, Florence ⁱ   Van Der Schouw, Yvonne T ^j   Simoncini, Tommaso ^k  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c CANTACUZINO INSTITUTE   (Romania)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e ISTANBUL UNIVERSITY   (Turkey)

^f UNIVERSITY OF ATHENS   (Greece)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ Paul Sabatier University   (France)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k UNIVERSITY OF PISA   (Italy)

more..

Author keywords

Calcineurin inhibitors; Clobetasol propionate; Corticosteroids; Dyspareunia; Lichen sclerosus; Pimecrolimus; Pruritus; Tacrolimus; Testosterone; Vulvar kraurosis

Indexed keywords

ANDROSTANOLONE; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CLOBETASOL PROPIONATE; CORTICOSTEROID; MOMETASONE FUROATE; PIMECROLIMUS; PLACEBO; PROGESTERONE; RETINOIC ACID; TACROLIMUS; TESTOSTERONE PROPIONATE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

APPLICATION SITE BURNING; APPLICATION SITE DRYNESS; APPLICATION SITE IRRITATION; ARTICLE; CLIMACTERIUM; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; EVENING DOSAGE; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HYPOPIGMENTATION; LICHEN SCLEROSUS ET ATROPHICUS; PATIENT COUNSELING; PHOTODYNAMIC THERAPY; POSTMENOPAUSE; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; SKIN ATROPHY; SKIN BIOPSY; TOPICAL TREATMENT; VULVA DISEASE; VULVECTOMY; ANALOGS AND DERIVATIVES; EARLY DIAGNOSIS; PRECANCEROUS CONDITIONS; VULVAR DISEASES; VULVAR LICHEN SCLEROSUS;

ADRENAL CORTEX HORMONES; CALCINEURIN INHIBITORS; EARLY DIAGNOSIS; FEMALE; HUMANS; PERIMENOPAUSE; POSTMENOPAUSE; PRECANCEROUS CONDITIONS; TACROLIMUS; VULVAR DISEASES; VULVAR LICHEN SCLEROSUS;

EID: 84884213286     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.12.006     Document Type: Article

References (44)

1. Ridley CM, Neill SM. Non-infective cutaneous conditions of the vulva. In: Ridley CM, Neill SM, editors. The vulva. Oxford: Blackwell Science; 1999. p. 121.
2. Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. Journal of the Royal Society of Medicine 1996;89:694-8.
3. McPherson T, Cooper S. Vulval lichen sclerosus and lichen planus. Dermatologic Therapy 2010;23:523-32.
4. Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. American Journal of Obstetrics and Gynecology 2008;198:496e1-3.
5. Neill S, Lewis FM, Tatnall FM, et al. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. British Journal of Dermatology 2010;163:672-82.
6. Royal College of Obstetricians and Gynaecologists. The management of vulval skin disorders. Green-top Guideline 58; February 2011 http://www.rcog.org.uk/files/rcog-corp/GTG58Vulval22022011.pdf [accessed 13.11.12].
7. Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. Journal of Reproductive Medicine 2005;50:477-80.
8. Leibovitz A, Kaplun VV, Saposhnicov N, Habot B. Vulvovaginal examinations in elderly nursing home women residents. Archives of Gerontology and Geriatrics 2000;31:1-4.
9. Eberz B, Berghold A, Regauer S. High prevalence of concomitant anogenital lichen sclerosus and extragenital psoriasis in adult women. Obstetrics and Gynecology 2008;111:1143-7.
10. Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Archives of Dermatology 2004;140:702-6.
11. Meyrick Thomas RH, Kennedy CT. The development of lichen sclerosus et atrophicus in monozygotic twin girls. British Journal of Dermatology 1986;114:377-9.
12. Cox NH, Mitchell JN, Morley WN. Lichen sclerosus et atrophicus in non-identical female twins. British Journal of Dermatology 1986;115:743.
13. Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. Journal of the European Academy of Dermatology and Venereology 2010;24:1031-4.
14. Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Archives of Dermatology 2008;144:1432-5.
15. Kazandi M, Sahin C, Terek MC, Cirpan T, Oztekin K. Clinical evaluation of vulvar lichen sclerosus: case series. European Journal of Gynaecological Oncology 2010;31:555-8.
16. Kreuter A, Wischnewski J, Terras S, Altmeyer P, Stücker M, Gambichler T. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. Journal of the American Academy of Dermatology 2012;67:1157-62.
17. Birenbaum DL, Young RC. High prevalence of thyroid disease in patients with lichen sclerosus. Journal of Reproductive Medicine 2007;52:28-30.
18. Simpkin S, Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psoriasis. Australasian Journal of Dermatology 2007;48:28-31.
19. Saunders H, Buchanan JA, Cooper S, Hollowood K, Sherman V, Wojnarowska F. The period prevalence of oral lichen planus in a cohort of patients with vulvar lichen sclerosus. Journal of the European Academy of Dermatology and Venereology 2010;24:18-21.
20. Berger MB, Damico NJ, Menees SB, Fenner DE, Haefner HK. Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. Journal of Lower Genital Tract Disease 2012;16:285-9.
21. Eisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Archives of Dermatology 2008;144:591-8.
22. Zollinger T, Mertz KD, Schmid M, Schmitt A, Pfaltz M, Kempf W. Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature. Journal of Cutaneous Pathology 2010;37:571-7.
23. Funaro D. Lichen sclerosus: a review and practical approach. Dermatologic Therapy 2004;17:28-37.
24. Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database of Systematic Reviews 2011;(12):CD008240.
25. Abramov Y, Elchalal U, Abramov D, Goldfarb A, Schenker JG. Surgical treatment of vulvar lichen sclerosus: a review. Obstetrical and Gynecological Survey 1996;51:193-9.
26. Goldstein AT, Creasey A, Pfau R, Phillips D, Burrows LJ. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. Journal of the American Academy of Dermatology 2011;64:e99-104.
27. Bradford J, Fischer G. Long-term management of vulval lichen sclerosus in adult women. Australian and New Zealand Journal of Obstetrics and Gynaecology 2010;50:148-52.
28. Simonart T, Lahaye M, Simonart JM. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease. Menopause 2008;15:74-7.
29. Cattaneo A, De Magnis A, Botti E, Sonni L, Carli P, Taddei GL. Topical mometasone furoate for vulvar lichen sclerosus. Journal of Reproductive Medicine 2003;48:444-8.
30. LeFevre C, Hoffstetter S, Meyer S, Gavard J. Management of lichen sclerosus with triamcinolone ointment: effectiveness in reduction of patient symptom scores. Journal of Lower Genital Tract Disease 2011;15: 205-9.
31. Stücker M, Grape J, Bechara FG, Hoffmann K, Altmeyer P. The outcome after cryosurgery and intralesional steroid injection in vulvar lichen sclerosus corresponds to preoperative histopathological findings. Dermatology 2005;210:218-22.
32. Ventolini G, Swenson KM, Galloway ML. Lichen sclerosus: a 5-year follow-up after topical, subdermal, or combined therapy. Journal of Lower Genital Tract Disease 2012;16:271-4.
33. Luesley DM, Downey GP. Topical tacrolimus in the management of lichen sclerosus. British Journal of Obstetrics and Gynaecology: An International Journal of Obstetrics and Gynaecology 2006;113:832-4.
34. Kim GW, Park HJ, Kim HS, et al. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement. Journal of Dermatology 2012;39:145-50.
35. Hengge UR, Krause W, Hofmann H, et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. British Journal of Dermatology 2006;155: 1021-8.
36. Kauppila S, Kotila V, Knuuti E, Väre PO, Vittaniemi P, Nissi R. The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus. American Journal of Obstetrics and Gynecology 2010;202: 181e1-4.
37. Bradford J, Fischer G. Surgical division of labial adhesions in vulvar lichen sclerosus and lichen planus. Journal of Lower Genital Tract Disease 2013;17(January):28-32.
38. Virgili A, Corazza M, Bianchi A, Mollica G, Califano A. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. Journal of Reproductive Medicine 1995;40:614-8.
39. British National Formulary. http://www.medicinescomplete.com/mc/bnf/ current/PHP7822-topical-retinoids-and-related-preparations-for-acne.htm [accessed 01.12.12].
40. Origoni M, Ferrari D, Rossi M, Gandini F, Sideri M, Ferrari A. Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. International Journal of Gynaecology and Obstetrics 1996;55: 259-64.
41. Shelley WB, Shelley ED, Amurao CV. Treatment of lichen sclerosus with antibiotics. International Journal of Dermatology 2006;45:1104-6.
42. Hillemanns P, Untch M, Pröve F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstetrics and Gynecology 1999;93:71-4.
43. Zawislak AA, McCluggage WG, Donnelly RF, et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatology, Photoimmunology and Photomedicine 2009;25: 111-3.
44. Rees M, Pérez-López FR, Ceasu I, et al. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy. Maturitas 2012;73: 171-4.